SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-17-007310
Filing Date
2017-11-28
Accepted
2017-11-28 08:31:03
Documents
4
Period of Report
2017-11-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_112817.htm 8-K 30300
2 EXHIBIT 10.1 exh_101.htm EX-10.1 176918
3 EXHIBIT 10.2 exh_102.htm EX-10.2 83894
4 EXHIBIT 99.1 exh_991.htm EX-99.1 7037
  Complete submission text file 0001171843-17-007310.txt   299414
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Filer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35443 | Film No.: 171224179
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences